Cargando…
Clinical Outcome and Drug Expenses of Intravitreal Therapy for Diabetic Macular Edema: A Retrospective Study in Sardinia, Italy
Background: Diabetic macular edema (DME) is a leading cause of visual loss in working-age adults. The purpose of this retrospective study was to perform an epidemiological analysis on DME patients treated with intravitreal drugs in a tertiary hospital. The clinical outcome, adverse drug reactions (A...
Autores principales: | Altana, Chiara, Donadu, Matthew Gavino, Dore, Stefano, Boscia, Giacomo, Carmelita, Gabriella, Zanetti, Stefania, Boscia, Francesco, Pinna, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619487/ https://www.ncbi.nlm.nih.gov/pubmed/34830624 http://dx.doi.org/10.3390/jcm10225342 |
Ejemplares similares
-
Intravitreal Therapy for Diabetic Macular Edema: An Update
por: Furino, Claudio, et al.
Publicado: (2021) -
Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2020) -
Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study
por: Giancipoli, Ermete, et al.
Publicado: (2018) -
DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
por: Furino, Claudio, et al.
Publicado: (2021) -
Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2017)